Barrow Robert (CIK 1897557) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-14). Recent activity: Buy DFTX (750,000 shares), Buy DFTX (40,000 shares), Sell DFTX (19,023 shares), Buy DFTX (375,000 shares), Sell DFTX (29,208 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Buy | 750,000 | $0 |
| 2026-09-04 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Buy | 40,000 | $0 |
| 2026-09-04 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Sell | 19,023 | $721,733 |
| 2026-08-12 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Buy | 375,000 | $0 |
| 2026-06-26 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Sell | 29,208 | $1.3M |
| 2026-06-22 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Buy | 375,000 | $0 |
| 2026-03-26 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Sell | 24,431 | $451,241 |
| 2026-02-05 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | Buy | 320,000 | $0 |
| 2025-12-29 | Mind Medicine (MindMed) Inc. (MNMD) | Chief Executive Officer | Sell | 25,791 | $339,152 |
| 2025-09-26 | Mind Medicine (MindMed) Inc. (MNMD) | Chief Executive Officer | Sell | 25,797 | $252,037 |
| 2025-06-26 | Mind Medicine (MindMed) Inc. (MNMD) | Chief Executive Officer | Sell | 26,491 | $180,139 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14